Mitoxantrone and VP-16 in refractory acute myelogenous leukemia

Haematol Blood Transfus. 1987:30:339-42. doi: 10.1007/978-3-642-71213-5_54.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Clinical Trials as Topic
  • Drug Administration Schedule
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Male
  • Middle Aged
  • Mitoxantrone / administration & dosage
  • Remission Induction

Substances

  • Etoposide
  • Mitoxantrone